Kevin Feeley
Chief Financial OfficerMr. Kevin Feeley, C.P.A., is Chief Financial Officer of GeneDx, Inc. Mr. Feeley served as a Chief Financial Officer and Director at Fabric Genomics, Inc. Mr. Feeley is Chief Financial Officer of GeneDx Holdings Corp. (formerly known as Sema4 Holdings Corp.) from August 25, 2022. He was Senior Vice President of Operations and Head of GeneDx of GeneDx Holdings Corp. (formerly known as Sema4 Holdings Corp.) He has leadership experience, with a focus on finance and accounting in the healthcare and pharmaceutical space. As Senior Vice President, Operations and Head of GeneDx at Sema4, he is responsible for key operational aspects of the company, including lab network operations, supply chain, customer service and genetic counseling services. He joined Sema4 after serving as Chief Financial Officer of OPKO Healths diagnostics from 2016 to 2022,division for six years, which includes BioReference Laboratories, Inc. and GeneDx, which was acquired by Sema4 in April 2022. Mr. Feeley held the position of Chief Financial Officer of BioReference Laboratories Inc. and GeneDx Inc. from January 2018 to April 2022. During the COVID-19 pandemic, Mr. Feeley led the operational design and execution of BioReferences sports diagnostic program serving all four major sports leagues in the U.S. He was U.S. Controller at Reckitt Benckiser, a global consumer packaged goods company focused on health, hygiene and nutrition brands. He also previously led SEC reporting at Bausch Health Companies, a public specialty pharmaceutical company and spent twelve years at KPMG LLP, with a focus on the pharmaceutical industry. He is a Certified Public Accountant and holds a BBA in Accounting from James Madison University.
Positions
- Company NameGeneDx Holdings Corp.Stock CodeWGSPositionChief Financial OfficerColleagues
- KAKatherine A. StuelandCEO & Director
- KAKeith Arlyn MeisterIndependent Chairman of the Board
- BMBryan M. DechairoChief Technology & Innovation Officer
- MAMark A. GardnerPresident
- SVSabrina V. DunbarDirector of Investor Relations & Communications
- JRJoshua RuchIndependent Director
- EMEmily Marine LeproustIndependent Director
- RCRichard C. PfennigerIndependent Director
